Nxera Pharma Co., Ltd. (SOLTF)
6.69
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Nxera Pharma EPS Diluted (Quarterly) : 0.1092 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PeptiDream Inc. | -0.0267 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.1082 |
| AnGes, Inc. | -0.0072 |
| SanBio Co., Ltd. | -0.095 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 11.43M |
| Revenue (Quarterly) | 71.74M |
| Total Expenses (Quarterly) | 60.31M |
| Enterprise Value | 883.45M |
| Gross Profit Margin (Quarterly) | 90.07% |
| Profit Margin (Quarterly) | 15.93% |
| Earnings Yield | -11.25% |
| Normalized Earnings Yield | -11.25 |